How would the US task force respond? On March 20, 2020, I watched as they commented on the news. The head of the NIAH had one word.
Without so much as a blink, I stared at the television in disbelief. I replayed the recording to make sure I had heard correctly. Yes, Dr. Fauci had used the word anecdotal to describe the results of a clinical trial, perhaps the most critical pilot study in the pandemic. As a medical professional, I was struck that something was amiss. Dismissing Raoult’s data as anecdotal was neither fair nor accurate. As I would soon discover, many of my colleagues felt the same. I would refer the reader to Appendix F for a collection of their comments.
Like Fauci, the CDC was also not impressed. They had lost their former enthusiasm. They preferred to wait, even as millions more became infected. But why wait with a medication already certified safe in FDA Phase I trials, a medication used for decades to treat lupus and malaria, and a medication that could save tens of thousands of lives?
Copyright © 2020 COVID-19 BOOK- All Rights Reserved.
Books discussed here are meant to provide information the reader should discuss with their physician to find what is appropriate for their particular situation. No patient should take action from a health book without first consulting their physician.
sponsored by WWW.HOPEPRESSWORKS.ORG